title: Interstitial photodynamic therapy in a rat liver metastasis model.
abstract: Photodynamic therapy (PDT) of hepatic tumours has been restricted owing to the preferential retention of photosensitizers in liver tissue. We therefore investigated interstitial tumour illumination as a means of selective PDT. A piece of colon carcinoma CC531 was implanted in the liver of Wag/Rij rats. Photofrin was administered (5 mg kg-1 i.v.) 2 days before laser illumination. Tumours with a mean (+/- s.e.) diameter of 5.7 +/- 0.1 mm (n = 106, 20 days after implantation) were illuminated with 625 nm light, at 200 mW cm-1 from a 0.5 cm cylindrical diffuser and either 100, 200, 400, 800 or 1600 J cm-1. Control groups received either laser illumination only, Photofrin only or diffuser insertion only. Short-term effects were studied on the second day after illumination by light microscopy and computer-assisted integration of the circumference of damaged areas. Long-term effects were studied on day 36. To determine the biochemistry of liver damage and function, serum ASAT and ALAT levels were measured on day 1 and 2, and antipyrine clearance on day 1. Tumour and surrounding liver necrosis increased with light dose delivered (P < 0.001). Best long-term results were obtained at 800 J cm-1 with complete tumour remission in 4 out of 6 animals. No deterioration in liver function was found. The results of this study show the ability of interstitial PDT to cause major destruction of tumour tissue in the liver combined with minimal liver damage.
authors.affiliation: Department of Surgery, Erasmus University, Medical Faculty, Rotterdam, The Netherlands.
authors.forename: R
authors.initials: R
authors.lastname: van Hillegersberg
authors.forename: J P
authors.initials: JP
authors.lastname: Marijnissen
authors.forename: W J
authors.initials: WJ
authors.lastname: Kort
authors.forename: P E
authors.initials: PE
authors.lastname: Zondervan
authors.forename: O T
authors.initials: OT
authors.lastname: Terpstra
authors.forename: W M
authors.initials: WM
authors.lastname: Star
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001831:Body Temperature; D003110:Colonic Neoplasms; D017324:Hematoporphyrin Derivative / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D008297:Male; D009336:Necrosis; D010778:Photochemotherapy / Q000379:methods*; D011897:Random Allocation; D051381:Rats; D012074:Remission Induction
chemical_list: D017324:Hematoporphyrin Derivative; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase